David Hoey is the CEO and director of the Vaxxas, a company working on enhancing the performance of existing and next generation vaccines through a novel vaccine delivery technology called Nanopatch. The Nanopatch approach consists of using thousands of vaccine coated microprojections that painlessly perforate into the outer layers of the skin. Th (Read more...)